{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:53:15Z","timestamp":1781830395544,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jgar.2022.03.014","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T21:37:44Z","timestamp":1648071464000},"page":"215-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Derivation of a score to predict infection due to multidrug-resistant Pseudomonas aeruginosa: a tool for guiding empirical antibiotic treatment"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4622-6278","authenticated-orcid":false,"given":"Pilar","family":"Hern\u00e1ndez-Jim\u00e9nez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"L\u00f3pez-Medrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0315-8001","authenticated-orcid":false,"given":"Mario","family":"Fern\u00e1ndez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose T.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3102-1352","authenticated-orcid":false,"given":"Laura","family":"Corbella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3446-1991","authenticated-orcid":false,"given":"Rafael","family":"San-Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1538-3043","authenticated-orcid":false,"given":"Mar\u00eda","family":"Ruiz-Ruig\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Lizasoain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2150-5748","authenticated-orcid":false,"given":"Isabel","family":"Rodr\u00edguez-Goncer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1393-6951","authenticated-orcid":false,"given":"Jazm\u00edn","family":"D\u00edaz-Rega\u00f1\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"L\u00f3pez-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Viedma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9520-8255","authenticated-orcid":false,"given":"Jos\u00e9 Mar\u00eda","family":"Aguado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2022.03.014_bib0001","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4065\/mcp.2010.0674","article-title":"Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa","volume":"86","author":"Kanj","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jgar.2022.03.014_bib0002","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/TP.0000000000000366","article-title":"Extensively drug-resistant Pseudomonas aeruginosa bacteremia in solid organ transplant recipients","volume":"99","author":"Bodro","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.jgar.2022.03.014_bib0003","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jinf.2012.10.028","article-title":"Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: the study, the patient, the bug or the drug?","volume":"66","author":"Vardakas","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.jgar.2022.03.014_bib0004","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2022.03.014_bib0005","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1472-6963-12-122","article-title":"Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition","volume":"12","author":"Morales","year":"2012","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jgar.2022.03.014_bib0006","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/2047-2994-3-32","article-title":"Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: systematic review and meta-analysis","volume":"3","author":"Nathwani","year":"2014","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jgar.2022.03.014_bib0007","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections, 1988","volume":"16","author":"Garner","year":"1988","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jgar.2022.03.014_bib0008","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.jgar.2022.03.014_bib0009","doi-asserted-by":"crossref","first-page":"106450","DOI":"10.1016\/j.ijantimicag.2021.106450","article-title":"Clinical and bacterial characteristics of Pseudomonas aeruginosa affecting the outcome of patients with bacteraemic pneumonia","volume":"58","author":"Recio","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2022.03.014_bib0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.jgar.2022.03.014_bib0011","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archinte.1962.03620240038007","article-title":"Gram-negative bacteremia: II. clinical, laboratory, and therapeutic observations","volume":"110","author":"McCabe","year":"1962","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jgar.2022.03.014_bib0012","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","article-title":"Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary","volume":"11","author":"Chow","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2022.03.014_bib0013","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1086\/379611","article-title":"Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa","volume":"37","author":"Linden","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jgar.2022.03.014_bib0014","first-page":"78","article-title":"Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: Guidelines by the Spanish Society of Chemotherapy","volume":"31","author":"Mensa","year":"2018","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.jgar.2022.03.014_bib0015","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/338782","article-title":"Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?","volume":"34","author":"Livermore","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2022.03.014_bib0016","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cmi.2019.06.034","article-title":"Weighting the impact of virulence on the outcome of Pseudomonas aeruginosa bloodstream infections","volume":"26","author":"Sanchez-Diener","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2022.03.014_bib0017","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01759-19","article-title":"Predictors of mortality in bloodstream infections caused by Pseudomonas aeruginosa and impact of antimicrobial resistance and bacterial virulence","volume":"64","author":"Recio","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.03.014_bib0018","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/jcm9020514","article-title":"Risk factors for mortality among patients with Pseudomonas aeruginosa bloodstream infections: what is the influence of XDR phenotype on outcomes?","volume":"9","author":"Montero","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jgar.2022.03.014_bib0019","first-page":"385","article-title":"Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug-resistant\/extensively drug-resistant\/pandrug-resistant bacteria","volume":"24","author":"Bassetti","year":"2018","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.jgar.2022.03.014_bib0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13756-018-0370-9","article-title":"Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis","volume":"7","author":"Raman","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"issue":"Pt 12","key":"10.1016\/j.jgar.2022.03.014_bib0021","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1099\/jmm.0.073262-0","article-title":"Pseudomonas aeruginosa bacteraemia: independent risk factors for mortality and impact of resistance on outcome","volume":"63","author":"Dantas","year":"2014","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jgar.2022.03.014_bib0022","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.25532","article-title":"Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study","volume":"55","author":"Fernandez","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jgar.2022.03.014_bib0023","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12072-012-9396-x","article-title":"The new epidemiology of nosocomial bacterial infections in cirrhosis: therapeutical implications","volume":"7","author":"Acevedo","year":"2012","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jgar.2022.03.014_bib0024","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.3748\/wjg.v22.i16.4201","article-title":"Influence of antibiotic-regimens on intensive-care unit-mortality and liver-cirrhosis as risk factor","volume":"22","author":"Friedrich-Rust","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jgar.2022.03.014_bib0025","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2018.10.027","article-title":"Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe","volume":"70","author":"Fern\u00e1ndez","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jgar.2022.03.014_bib0026","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/cid\/cir813","article-title":"Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department","volume":"54","author":"Shorr","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2022.03.014_bib0027","article-title":"Development and assessment of risk scores for carbapenem and extensive beta-lactam resistance among adult hospitalized patients with Pseudomonas aeruginosa infection","volume":"1","author":"Tartof","year":"2018","journal-title":"JAMA New Open"},{"key":"10.1016\/j.jgar.2022.03.014_bib0028","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1128\/AAC.01758-13","article-title":"A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa","volume":"58","author":"Voor In \u2019t Holt","year":"2014","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716522000662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716522000662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:57:35Z","timestamp":1761991055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716522000662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":28,"alternative-id":["S2213716522000662"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2022.03.014","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Derivation of a score to predict infection due to multidrug-resistant Pseudomonas aeruginosa: a tool for guiding empirical antibiotic treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2022.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}